logo
logo
ENSG stock ticker logo

The Ensign Group, Inc.

NASDAQ•ENSG
CEO: Mr. Christopher R. Christensen
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2007-11-09
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Contact Information
29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA, 92675, United States
949-487-9500
ensigngroup.net
Market Cap
$12.19B
P/E (TTM)
35.1
54.1
Dividend Yield
0.1%
52W High
$218.00
52W Low
$118.73
52W Range
92%
Rank25Top 11.9%
5.6
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$1.36B+0.00%
4-Quarter Trend

EPS

$1.66+0.00%
4-Quarter Trend

FCF

$133.48M+0.00%
4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Total Revenue Growth Strong Total revenue reached $5.06B USD, marking an 18.7% increase over prior year results, showing strong momentum.
Net Income Attributable Rises Net income attributable to Ensign grew to $344.0M USD, reflecting 15.4% growth compared to the previous period.
Same Facility Occupancy Improves Same Facility operational bed occupancy reached 82.9%, a 2.0 percentage point increase from 2024 performance metrics.
Skilled Mix Revenue Percentage Climbs Skilled mix revenue percentage climbed to 49.4% of total skilled revenue, up 0.8 percentage points year-over-year.

Risk Factors

Reimbursement Rate Reductions Medicare and Medicaid rate changes, spending requirements, and evaluation standards pose material adverse effects on revenues.
Increased Labor Cost Competition Shortage of nurses and skilled personnel increases staffing labor costs, potentially leading to monetary fines under state laws.
Regulatory Scrutiny and Audits Subject to extensive government reviews, audits, and investigations, risking refunds, fines, and potential loss of licensure.
Litigation Exposure Remains High High risk of liability from patient claims, with increased damage caps in states like California potentially increasing costs.

Outlook

Continued Acquisition Expansion Focus Plan to continue acquiring additional operations in existing and new markets, building on 46 new additions in 2025.
Grow Talent Base Development Primary growth strategy involves expanding talent base and developing future leaders through rigorous training programs.
Increase High Acuity Patient Mix Focus on increasing overall percentage mix of higher acuity patients to capture higher reimbursement rates effectively.
Real Estate Portfolio Growth Committed to growing the real estate portfolio, viewing owned properties as a key component for sustained earnings growth.

Peer Comparison

Revenue (TTM)

MOH stock ticker logoMOH
$45.43B
+11.7%
UHS stock ticker logoUHS
$17.36B
+9.7%
DVA stock ticker logoDVA
$13.64B
+6.5%

Gross Margin (Latest Quarter)

EXEL stock ticker logoEXEL
95.6%
+0.1pp
BMRN stock ticker logoBMRN
66.3%
+7.2pp
ALGN stock ticker logoALGN
65.7%
-5.5pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
UHS$12.23B8.221.0%34.5%
ENSG$12.19B35.116.6%76.1%
ALGN$11.78B28.710.4%1.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
5.1%
Steady Growth
4Q Net Income CAGR
5.9%
Profitability Improving
Cash Flow Stability
100%
Strong Cash Flow

Deep Research

Next earnings:Apr 23, 2026
|
EPS:$1.82
|
Revenue:$1.40B
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data